Viemed Healthcare (VMD) Common Equity (2018 - 2026)

Viemed Healthcare's Common Equity history runs 9 years deep, the most recent figure standing at $145.8 million for Q1 2026.

• Quarterly Common Equity rose 6.62% year-over-year to $145.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $145.8 million (up 6.62% YoY) and the FY2025 annual result came in at $143.5 million, up 7.67% from the prior year.
• Common Equity was $145.8 million for Q1 2026 at Viemed Healthcare, up from $143.5 million in the prior quarter.
• Across five years, Common Equity topped out at $145.8 million in Q1 2026 and bottomed at $93.2 million in Q2 2022.
• A 5-year average of $118.1 million and a median of $116.3 million in 2024 frame the typical range for Common Equity.
• Annual changes were most pronounced in 2022 — Common Equity increased 2.4% — and 2025, when it increased 17.61%.
• Viemed Healthcare's Common Equity stood at $97.1 million in 2022, then advanced by 17.3% to $113.9 million in 2023, then advanced by 17.04% to $133.3 million in 2024, then grew by 7.67% to $143.5 million in 2025, then climbed by 1.59% to $145.8 million in 2026.
• Business Quant data shows VMD's Common Equity at $145.8 million in Q1 2026, $143.5 million in Q4 2025, and $135.5 million in Q3 2025.